Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness.
OBJECTIVE: To study the effectiveness of ibuprofen versus placebo in preventing acute mountain sickness (AMS) and high altitude headache (HAH). METHODS: Double-blind, randomized, placebo-controlled trial. RESULTS: Two hundred ninety-four healthy Western trekkers were recruited on the Everest approac...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797084098189066240 |
|---|---|
| author | Gertsch, J Corbett, B Holck, P Mulcahy, A Watts, M Stillwagon, N Casto, A Abramson, C Vaughan, C Macguire, C Farzan, N Vo, B Norvelle, R May, K Holly, J Irons, H Stutz, A Chapagain, P Yadav, S Pun, M Farrar, J Basnyat, B |
| author_facet | Gertsch, J Corbett, B Holck, P Mulcahy, A Watts, M Stillwagon, N Casto, A Abramson, C Vaughan, C Macguire, C Farzan, N Vo, B Norvelle, R May, K Holly, J Irons, H Stutz, A Chapagain, P Yadav, S Pun, M Farrar, J Basnyat, B |
| author_sort | Gertsch, J |
| collection | OXFORD |
| description | OBJECTIVE: To study the effectiveness of ibuprofen versus placebo in preventing acute mountain sickness (AMS) and high altitude headache (HAH). METHODS: Double-blind, randomized, placebo-controlled trial. RESULTS: Two hundred ninety-four healthy Western trekkers were recruited on the Everest approach at 4280 m or 4358 m and randomly assigned to receive either 600 mg of ibuprofen or placebo 3 times daily before and during ascent to 4928 m. One hundred eighty-three of 294 participants completed the trial. Of the participants who did not complete the trial, 62 were lost to follow-up and another 49 broke trial protocol. In an intent-to-treat analysis (232 participants), ibuprofen was found to be more effective than placebo in reducing the incidence of AMS (24.4% vs 40.4%; P = .01) and the incidence of HAH (42.3% vs 60.5%; P < .01). Ibuprofen was also superior to placebo in reducing the severity of HAH (4.9% vs 14.7%; P = .01). The end point of oxygen saturation was also higher in the ibuprofen group (80.8 % vs 82.4%; P = .035). For the 183 participants who completed the trial and conformed to the protocol, the incidence of AMS between placebo and treatment groups was not significant (32.9% vs 22.7%; P = .129 for AMS incidence, 9.6% vs 8.2%; P = .74 for AMS severity, 54.8% vs 42.7%; P = .11 for HAH incidence, and 8.2% vs 3.6%; P = .18 for HAH severity). CONCLUSIONS: Ibuprofen was found to be effective in preventing AMS in the intent-to-treat analysis group but not in those who completed the trial. This loss of significance in the subjects who completed the trial may be explained by persons in the placebo group having a higher burden of illness and associated decreased compliance with the protocol. An important limitation of this study may be the possibility that ibuprofen can mask headache, which is a compulsory criterion for the diagnosis of AMS. |
| first_indexed | 2024-03-07T01:50:39Z |
| format | Journal article |
| id | oxford-uuid:99f91097-d3ed-4f52-bced-5587834f1373 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:50:39Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:99f91097-d3ed-4f52-bced-5587834f13732022-03-27T00:18:08ZAltitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:99f91097-d3ed-4f52-bced-5587834f1373EnglishSymplectic Elements at Oxford2012Gertsch, JCorbett, BHolck, PMulcahy, AWatts, MStillwagon, NCasto, AAbramson, CVaughan, CMacguire, CFarzan, NVo, BNorvelle, RMay, KHolly, JIrons, HStutz, AChapagain, PYadav, SPun, MFarrar, JBasnyat, BOBJECTIVE: To study the effectiveness of ibuprofen versus placebo in preventing acute mountain sickness (AMS) and high altitude headache (HAH). METHODS: Double-blind, randomized, placebo-controlled trial. RESULTS: Two hundred ninety-four healthy Western trekkers were recruited on the Everest approach at 4280 m or 4358 m and randomly assigned to receive either 600 mg of ibuprofen or placebo 3 times daily before and during ascent to 4928 m. One hundred eighty-three of 294 participants completed the trial. Of the participants who did not complete the trial, 62 were lost to follow-up and another 49 broke trial protocol. In an intent-to-treat analysis (232 participants), ibuprofen was found to be more effective than placebo in reducing the incidence of AMS (24.4% vs 40.4%; P = .01) and the incidence of HAH (42.3% vs 60.5%; P < .01). Ibuprofen was also superior to placebo in reducing the severity of HAH (4.9% vs 14.7%; P = .01). The end point of oxygen saturation was also higher in the ibuprofen group (80.8 % vs 82.4%; P = .035). For the 183 participants who completed the trial and conformed to the protocol, the incidence of AMS between placebo and treatment groups was not significant (32.9% vs 22.7%; P = .129 for AMS incidence, 9.6% vs 8.2%; P = .74 for AMS severity, 54.8% vs 42.7%; P = .11 for HAH incidence, and 8.2% vs 3.6%; P = .18 for HAH severity). CONCLUSIONS: Ibuprofen was found to be effective in preventing AMS in the intent-to-treat analysis group but not in those who completed the trial. This loss of significance in the subjects who completed the trial may be explained by persons in the placebo group having a higher burden of illness and associated decreased compliance with the protocol. An important limitation of this study may be the possibility that ibuprofen can mask headache, which is a compulsory criterion for the diagnosis of AMS. |
| spellingShingle | Gertsch, J Corbett, B Holck, P Mulcahy, A Watts, M Stillwagon, N Casto, A Abramson, C Vaughan, C Macguire, C Farzan, N Vo, B Norvelle, R May, K Holly, J Irons, H Stutz, A Chapagain, P Yadav, S Pun, M Farrar, J Basnyat, B Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. |
| title | Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. |
| title_full | Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. |
| title_fullStr | Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. |
| title_full_unstemmed | Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. |
| title_short | Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. |
| title_sort | altitude sickness in climbers and efficacy of nsaids trial ascent randomized controlled trial of ibuprofen versus placebo for prevention of altitude illness |
| work_keys_str_mv | AT gertschj altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT corbettb altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT holckp altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT mulcahya altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT wattsm altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT stillwagonn altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT castoa altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT abramsonc altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT vaughanc altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT macguirec altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT farzann altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT vob altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT norveller altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT mayk altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT hollyj altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT ironsh altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT stutza altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT chapagainp altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT yadavs altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT punm altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT farrarj altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness AT basnyatb altitudesicknessinclimbersandefficacyofnsaidstrialascentrandomizedcontrolledtrialofibuprofenversusplaceboforpreventionofaltitudeillness |